Unlock the Editor’s Digest for free
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.
Two of the world’s biggest drugmakers — AstraZeneca and MSD — have hailed progress in tackling hard-to-treat cancers, presenting data that showed improved treatment of advanced bladder cancer and a form of breast cancer.
The news came in separate studies published in the New England Journal of Medicine on Sunday and simultaneously presented at this week’s…
Read the full article here